Microbiomes more in flux in patients with inflammatory bowel disease

February 13, 2017
Credit: Pacific Northwest National Laboratory

Patients with inflammatory bowel disease are more likely to see dramatic shifts in the make-up of the community of microbes in their gut than healthy people, according to the results of a study published online Feb. 13 in Nature Microbiology.

While scientists have known that there are differences in the bacteria and other that make up the gut microbiome in IBD patients, this is one of the largest studies to watch the microbiome over a period of time. The findings indicate that the biggest difference in the microbiome of patients is the way it fluctuates - what the researchers call "volatile dysbiosis."

The results help physicians and scientists understand the disease more fully and potentially offer new ways to track the disease and monitor patients.

The findings come from a team of scientists from Sweden, Spain, Germany and the United States. Janet Jansson of the Department of Energy's Pacific Northwest National Laboratory is the corresponding author of the paper.

"We know that there are some key beneficial microbes that are lower in number in people with inflammatory . Sometimes the differences are quite substantial," said Jansson. "Our latest results show that patients affected by this condition also have a much less stable gut microbiome than ."

Fluctuating microbiome, fluctuating symptoms

IBD encompasses a group of diseases where the body's immune system attacks microbes in the gut, causing chronic inflammation in the digestive tract and giving rise to symptoms such as diarrhea, abdominal pain, and other unpleasant and sometimes life-threatening symptoms. Many patients have periods when the condition causes minor problems, then flares up and becomes more serious. Medications such as powerful anti-inflammatory drugs and steroids are common treatments, and surgery is an option in severe cases.

The video will load shortly.
Microbes are more in flux in patients with inflammatory bowel disease than their healthy counterparts, sometimes changing dramatically. Credit: PNNL

Scientists know that there are some differences in the microbiomes of patients with IBD patients compared to healthy people - for instance, patients generally have fewer and they are more likely to carry bacteria such as Enterobacteriaceae and E. coli. But questions remain.

"It's important to know not just what microbes are present, but also to understand how the microbial community changes as patients' symptoms improve or worsen over time," said author Colin Brislawn, a PNNL scientist who contributed to the statistical analysis. "We explored the dynamic nature of the disease as it relates to the dynamic nature of the human ."

To do the study, gastroenterologist Jonas Halfvarson of Örebro University in Sweden and colleagues studied 137 people for two years. Participants included patients with ulcerative colitis, colonic Crohn's disease, ileal Crohn's disease, and healthy controls. Physicians collected fecal samples from patients every three months for up to two years and monitored patients' symptoms. Overall 683 fecal samples were collected. Scientists then used genetic sequencing technology to identify the microbes in the samples.

The team found that in healthy people, the gut microbial community is much more consistent over time than in patients with IBD. Patients with IBD have dramatic shifts in their microbiomes, with some bacteria disappearing almost completely at times - something that rarely happened in the healthy people studied. In some IBD patients, more than half their microbiome was displaced by other microbes in just a few months. The biggest swings were seen in patients with ileal Crohn's disease who had had part of their intestine removed to alleviate their symptoms.

The scientists also noted that changes in medication to treat the disease affected the microbiome; for example, patients who had taken steroids as part of treatment had more fluctuations in their microbiome than patients who had not. And patients who were experiencing a flare-up in their symptoms were more likely to have dramatic fluctuations in their microbiome.

The scientists say the findings might one day contribute to the diagnosis of patients or allow physicians to follow the course of the disease and track the effectiveness of medication in patients more closely.

"The results are an important step in our aim to understand how the microbiome relates to the dynamics of ," said Halfvarson. "Ultimately, manipulation of the microbiome, aiming to mimic the situation and the trajectories of healthy individuals, might become an attractive treatment strategy to maintain IBD in remission, especially if immunosuppressants such as corticosteroids can be avoided."

Explore further: Genes, early environment sculpt the gut microbiome

More information: Jonas Halfvarson et al, Dynamics of the human gut microbiome in inflammatory bowel disease, Nature Microbiology (2017). DOI: 10.1038/nmicrobiol.2017.4

Related Stories

Genes, early environment sculpt the gut microbiome

November 28, 2016
Genetics and birthplace have a big effect on the make-up of the microbial community in the gut, according to research published Nov. 28. in the journal Nature Microbiology.

Researchers discover what makes drug for ulcerative colitis tick

January 23, 2017
For approximately 70 years, physicians have used a medication containing the active agent mesalamine to treat ulcerative colitis, but little was known about how the drug targeted the inflammatory bowel disease.

Vaginal microbes point toward early detection and screening for endometrial cancer

January 5, 2017
Endometrial cancer triggers remain elusive, despite continued research. But given the typical inflammatory profile in these cases, microbes in the uterine environment are suspected to play a role in the development of this ...

People susceptible to atopic dermatitis have different microbes living on their skin than non-sufferers

July 27, 2016
Microbial communities living on the skin of people susceptible to the skin disease atopic dermatitis differ from those of healthy individuals. This finding by A*STAR researchers provides insight into the roles that resident ...

Special diet may be boon for kids with Crohn's, colitis

January 10, 2017
(HealthDay)—Children with Crohn's disease and ulcerative colitis may be able to achieve relief without medications by eating a special diet, a small study suggests.

Insights into the ecology of the microbiome

June 13, 2016
The microbiome is like a fingerprint: every person's community of microbes is complex and unique. But the underlying dynamics, the interactions between the microbes that shape these microbial ecosystems, may have something ...

Recommended for you

Lactation hormone also helps a mother's brain

September 26, 2017
The same hormone that stimulates milk production for lactation, also acts in the brain to help establish the nurturing link between mother and baby, University of Otago researchers have revealed for the first time.

Image ordering often based on factors other than patient need: study

September 25, 2017
Do you really need that MRI?

Bone marrow concentrate improves joint transplants

September 25, 2017
Biologic joint restoration using donor tissue instead of traditional metal and plastic may be an option for active patients with joint defects. Although recovery from a biologic joint repair is typically longer than traditional ...

Researchers describe mechanism that underlies age-associated bone loss

September 22, 2017
A major health problem in older people is age-associated osteoporosis—the thinning of bone and the loss of bone density that increases the risk of fractures. Often this is accompanied by an increase in fat cells in the ...

Researchers develop treatment to reduce rate of cleft palate relapse complication

September 22, 2017
Young people with cleft palate may one day face fewer painful surgeries and spend less time undergoing uncomfortable orthodontic treatments thanks to a new therapy developed by researchers from the UCLA School of Dentistry. ...

Exosomes are the missing link to insulin resistance in diabetes

September 21, 2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.